CLBIO — Corline Biomedical AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Corline Biomedical AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2019 December 31st	R2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	SAS	SAS	SAS	SAS	SAS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	22.9	8.9	41.6	26.2	17
Net Total Accounts Receivable
Net Total Receivables	1.69	1.67	2.77	8.47	5.22
Prepaid Expenses
Total Current Assets	25	11	44.8	36	23.8
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.037	0.073	0.182	0.28	0.314
Net Intangible Assets
Long Term Investments
Total Assets	63.8	58.5	102	102	100
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	4.43	6.24	9.43	7.19	6.79
Total Long Term Debt
Total Debt
Total Liabilities	4.43	6.24	9.43	7.19	6.79
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	59.3	52.2	92.2	94.6	93.3
Total Liabilities & Shareholders' Equity	63.8	58.5	102	102	100
Total Common Shares Outstanding